Swine influenza vaccine (A/H3N2v)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Swine influenza vaccine (A/H3N2v), covering 2016-02-17 to 2016-02-17. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to <65 Years and Elderly 65 Years and Older. [Phase 1]